Member Info for plumbs

doubt it as it will be suspended in Oz until Monday...gives them enough time to address everything.

Wouldn't be a bad thing if MIIF come on board now..

and uk is so clean when it comes to corruption :)

have they replied?

surprised there's been no news of significance since the big discounted placing

you need to have some proper news for blue ticks to be sustained.....

PJ100 -you need to enjoy your life a little more , your really wasting it

anyone could take the placing up as it's at substantial discount to price few days ago...

fallen off a cliff?

really can't understand why no one puts a bid in for this buys this out....look at the resource and a company progressing way too slowly..

Nice rns this morning

"The impacts of KidneyIntelX early risk assessment, at 90 days and 180 days, are very encouraging as we can now state that we have observed early intervention in the highest risk patients can result in positive clinical outcomes, before kidney disease advances to a critical point. This prospective study in a real-world health care system setting demonstrates that risk informed care in the earliest stages of chronic kidney disease is not just a vision, it's a reality. Until the introduction of KidneyIntelX testing, there has not been a good way to allocate time and attention in the PCP practice to those patients at highest risk for progression to end stage renal disease. This published data shows that KidneyIntelX can help to drive urgency to action and increase patient engagement in the management of their disease."

"These groundbreaking results demonstrate that we have the opportunity to make a tangible difference today in two of the most complex chronic disease conditions that the U.S. faces today: type 2 diabetes and chronic kidney disease. These results represent a triple win - they're good for the patient, they're good for the provider, they're good for the payer. We look forward to continuing to advance our clinical development program and to additional published data releases at the one-year mark," added Thomas McLain, President, Renalytix.

Jatw , i read the latest release and not what it said...it's clear that they have enough cash for bulk for 2023 unless i've missed something?

when is FDA approval expected?

Just wondering why this is not trading at a higher share price?

88e is almost £100m but no production (as far i'm aware) and this is just over £200m will over 20kbopd and increasing to 24k this qtr .....plus a dividend

Extract from last financials
" The benefits of this drilling success will be largely realised in 2023 as most of the production growth commenced in the second half of the year."

25p close ...don't look like it showing any signs of slowing..

excellant news this morning...
and maybe an acq to follow soon

thanks

Plz guys as im quite new to this , what is bull and bear case here....can someone summarize as it seems a little complicated

Quite a drop from there highs few years back, but can this recover,perhaps even double in share price next year?

6p paid now...

too dangerous to buy as it keeps going into auction

not even end of the month...and why did they not give bid extensions?